These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12710689)

  • 1. Progression model of prostate cancer.
    Almeida TA; Papadopoulos N
    Methods Mol Biol; 2003; 222():211-22. PubMed ID: 12710689
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
    Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.
    Kasper S; Smith JA
    J Urol; 2004 Jul; 172(1):12-9. PubMed ID: 15201729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer progression and survival in BRCA2 mutation carriers.
    Tryggvadóttir L; Vidarsdóttir L; Thorgeirsson T; Jonasson JG; Olafsdóttir EJ; Olafsdóttir GH; Rafnar T; Thorlacius S; Jonsson E; Eyfjord JE; Tulinius H
    J Natl Cancer Inst; 2007 Jun; 99(12):929-35. PubMed ID: 17565157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New concepts regarding the relationship of testosterone and prostate cancer.
    Morgentaler A
    Future Oncol; 2007 Apr; 3(2):123-6. PubMed ID: 17381410
    [No Abstract]   [Full Text] [Related]  

  • 7. Stem cells: The root of prostate cancer?
    Kasper S
    J Cell Physiol; 2008 Aug; 216(2):332-6. PubMed ID: 18459113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of prostate cancer progression to androgen independence.
    McPhaul MJ
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):373-88. PubMed ID: 18471793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.
    Majeed N; Blouin MJ; Kaplan-Lefko PJ; Barry-Shaw J; Greenberg NM; Gaudreau P; Bismar TA; Pollak M
    Oncogene; 2005 Jul; 24(29):4736-40. PubMed ID: 15870705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial stem cells of the prostate and their role in cancer progression.
    Lukacs RU; Lawson DA; Xin L; Zong Y; Garraway I; Goldstein AS; Memarzadeh S; Witte ON
    Cold Spring Harb Symp Quant Biol; 2008; 73():491-502. PubMed ID: 19022743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
    Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
    Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
    Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of p53 are common in early stage prostate cancer.
    Downing SR; Russell PJ; Jackson P
    Can J Urol; 2003 Aug; 10(4):1924-33. PubMed ID: 14503938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles of chemokines in prostate cancer.
    Vindrieux D; Escobar P; Lazennec G
    Endocr Relat Cancer; 2009 Sep; 16(3):663-73. PubMed ID: 19556286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural selection and the endocrinology of prostatic cancer: aging's debts from a fit youth.
    Taylor GT
    Growth Dev Aging; 1990; 54(1-2):3-5. PubMed ID: 2210918
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased expression of osteopontin contributes to the progression of prostate cancer.
    Khodavirdi AC; Song Z; Yang S; Zhong C; Wang S; Wu H; Pritchard C; Nelson PS; Roy-Burman P
    Cancer Res; 2006 Jan; 66(2):883-8. PubMed ID: 16424021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression.
    Knudsen BS; Miranti CK
    J Cell Biochem; 2006 Oct; 99(2):345-61. PubMed ID: 16676354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular changes in prostatic cancer.
    Bott SR; Arya M; Shergill IS; Williamson M
    Surg Oncol; 2005 Aug; 14(2):91-104. PubMed ID: 15993579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.